|
On april 15th, 2025, fujifilm healthcare americas corporation was informed by fujifilm medwork gmbh of the reportable event involving val1-f1-100 from the manufacturer.During an fda-inspection on (b)(6) 2025, it was found that complaint involving the val1-f1-100 was not evaluated for reportability to the fda.Therefore, val1-f1-100 complaint received prior to the inspection were evaluated for fda mdr.Fujifilm medwork gmbh received this complaint on (b)(6) 2025, determined it to be reportable (mdr 3020707080-2025-00002 submitted on april 16th, 2025).During a colonoscopy therapy, using a pentax endoscope and fujifilm val1-f1-100 valve, the membrase has not opened during the introduction of a syringe, and the introduction of the endoscopy is sometimes really difficult.It created a situation of potential spattering since it demands to open the cork of the valve.No patient injury reported.
|